Carfentanil, C-11

DB15360InvestigationalSmall molecule

Carfentanil, C-11 is under investigation in clinical trial NCT01899170 (Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain).

Mechanism: Pharmacologically active on Mu-type opioid receptor
Curator reviewed
Formula / weight: C₂₄H₃₀N₂O₃ · 393.515 g/mol (avg)
Also known as: 11C-CARFENTANIL

Resolves to

Compound

UNIIUVI40IC2GNCAS98598-83-5ChEMBLCHEMBL2311157

Structure

InChIKeyYDSDEBIZUNNPOB-JVVVGQRLSA-NSMILESCCC(=O)N(C1=CC=CC=C1)C1(CCN(CCC2=CC=CC=C2)CC1)C(=O)O[11CH3]

Targets

P35372OPRM1

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

913Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Carfentanil, C-11, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account